COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK

Pioneering collaboration with King’s College London and South London and Maudsley NHS Foundation Trust
London, UK, 24 March 2022
COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has formed a long-term strategic partnership to launch The Centre for Mental Health Research and Innovation (“the Centre”) to accelerate psychedelic research and develop new models of care for mental health in the UK.
Together with South London and Maudsley NHS Foundation Trust (SLaM), the largest mental health trust in the UK National Health Service (NHS) and the …

Read the source article at Biotech and Healthcare Stock Market News
2022-03-24 07:00:00